BioAgilytix

02/02/2024

In observance of Black History Month, we, at BioAgilytix, take immense pride in our unwavering commitment to promoting diversity, equity, and inclusion in all aspects of our business. Our Black Employee Network (BEN), a crucial part of our Employee Resource groups, plays a significant role in realizing this commitment. BEN's primary objective is to facilitate a deeper understanding of the issues affecting the Black and African American community. Moving forward, we are resolute in our pledge to create an environment where everyone, irrespective of their background, can thrive and be their authentic selves. This month, let us pay tribute to the remarkable history and contributions of Black Americans and continue our efforts to foster diversity and inclusion every day.

Learn more about our focus on diversity, equity, and inclusion. https://bit.ly/481Mgee

Our purpose and values Partnering with our clients to deliver bioanalytical solutions, so the therapeutics breakthroughs of tomorrow keep advancing every

01/18/2024

Are you on the hunt for a career where you can truly make a difference? As a front-runner in providing contract bioanalytical testing services, we're not just on the cutting edge; we're setting the pace for scientific research and discovery.

But what truly distinguishes us is our commitment to our exceptional team. At BioAgilytix, we don't just see our employees as contributors; we recognize them as our greatest asset. We go above and beyond to ensure that every member of our team has the resources, support, and opportunities required not just to succeed but to thrive.

Learn More https://bit.ly/4119v6n

02/23/2023

In a recent article published in International Pharmaceutical Industry, BioAgilytix’s Chief Scientific Officer Jim McNally, PhD explores why bioanalysts should prepare for the impending wave of cell and gene therapies. He also explores the factors they must consider in their pre-existing immunogenicity assessments. Read the article: https://bit.ly/40U21By

IPI Volume 14 Issue 4

02/14/2023

Roses are red, violets are blue.
We 💙 Science. How about you?

Happy Valentine's Day! 💘

02/12/2023

International Day of Women & Girls in Science, we celebrate and honor the at BioAgilytix for their contribution to research and innovation.

02/03/2023

When a person has a cardiac arrest, survival depends on immediately receiving CPR from someone nearby.

On Wear Red Day, in honor of American Heart Month, we invite you to help your community by learning the 2 simple steps of Hands-Only CPR >> https://bit.ly/3K2BFE5

02/02/2023

Black History Month serves as a powerful reminder that Black history is essential to the ongoing story of the world. We celebrate diversity and work toward a global future free from racism and discrimination.

01/30/2023

January is . Glaucoma has no warning signs, and half of those with glaucoma don’t know they have it. Get the facts and schedule a dilated eye exam. Learn more about how to protect your sight through a dilated eye exam at http://ow.ly/UIlE8

01/26/2023

BioAgilytix was founded to help the pharmaceutical and biotechnology community more effectively bring therapeutics to market by providing the bioanalysis expertise necessary to navigate the scientific and regulatory complexities inherent in drug development.

Join our growing team. Find out about open positions on our website >> http://gag.gl/BHSmB7

01/24/2023

BioAgilytix Scientific Officer and Senior Director, Amanda Hays, Ph.D., joins a panel of experts to discuss new modalities and their implementation into the bioanalytical field. Register now to hear the discussion >> https://bit.ly/3wm6BKM

This webinar will highlight how bioanalytical strategies for implementing biomarkers in clinical trials will be presented.

01/23/2023

Check out our latest "Science in 60" video, featuring Analyst Robert Beck from our Boston lab, to learn about the MSD U-Plex assay technology for biomarker multiplexing: https://youtu.be/lSBTFiIhEa0

About BioAgilytixSee what makes BioAgilytix a different kind of bioanalytical contract research organization... and the choice for pharmaceutical and biotech...